MARKET

BDSI

BDSI

BDSI
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.070
+0.020
+0.49%
After Hours: 4.070 0 0.00% 16:30 09/18 EDT
OPEN
4.100
PREV CLOSE
4.050
HIGH
4.130
LOW
4.030
VOLUME
1.00M
TURNOVER
--
52 WEEK HIGH
7.21
52 WEEK LOW
2.850
MARKET CAP
410.80M
P/E (TTM)
77.23
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average BDSI stock price target is 8.00 with a high estimate of 9.00 and a low estimate of 7.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BDSI
BioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved products BUNAVAIL (buprenorphine and naloxone buccal film) buccal film and BELBUCA (buprenorphine) buccal film, utilize BEMA technology.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BioDelivery Sciences International, Inc. stock information, including NASDAQ:BDSI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDSI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BDSI stock methods without spending real money on the virtual paper trading platform.